Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

Actions
  • Price (USD)1.52
  • Today's Change-0.01 / -0.65%
  • Shares traded53.33k
  • 1 Year change+20.40%
  • Beta0.6129
Data delayed at least 20 minutes, as of Jul 04 2024 16:50 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for investment trust price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on $1000

1Y
Fund/benchmarkChange
PriceRTW Biotech Opportunities Ltd (Ordinary Share)+15.04%
NAVRTW Biotech Opportunities Ltd (Ordinary Share)+7.74%
Morningstar's Benchmark(Russell 2000 Biotech Growth) 50.000% + ( Nasdaq Biotechnology Index) 50.000%--

Key statistics

On Thursday, RTW Biotech Opportunities Ltd (RTW:LSE) closed at 1.52, -5.00% below its 52-week high of 1.60, set on Jun 17, 2024.
52-week range
Today
1.05Nov 02 20231.60Jun 17 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding335.71m
Market cap513.64m USD
Total assets607.64m USD
Total expense ratio1.97%
High1.54
Low1.52
Previous close1.53
Average volume98.70k
YTD Change+8.38%
Beta0.6129
Diluted NAV (est)1.81
Diluted NAV (last pub)1.81
Premium/Discount-16.02%
Net Gearing0.00%
Data delayed at least 20 minutes, as of Jul 04 2024 16:50 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.